Skip to main content

Advertisement

Log in

Neurogenesis within the hippocampus after chronic methylphenidate exposure

  • Psychiatry and Preclinical Psychiatric Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Methylphenidate is a psychostimulant used to treat attention deficit hyperactivity disorder. Neurogenesis occurs throughout adulthood within the dentate gyrus of the hippocampus and can be altered by psychoactive medications; however, the impact of methylphenidate on neurogenesis is not fully understood. We investigated the effects of chronic low (1 mg/kg) and high (10 mg/kg) intraperitoneal doses of methylphenidate on neurogenesis in mouse hippocampus following 28 days and 56 days of treatment. Interestingly, methylphenidate, at both doses, increased neurogenesis. However, if methylphenidate treatment was not continued, the newly generated cells did not survive after 28 days. If treatment was continued, the newly generated neurons survived only in the mice receiving low-dose methylphenidate. To investigate the mechanism for this effect, we examined levels of proteins linked to cell proliferation in the hippocampus, including brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), vascular endothelial growth factor (VEGF), tropomyosin receptor kinase B (TrkB), and beta-catenin. BDNF or GDNF levels were not significantly different between groups. However, hippocampal VEGF, TrkB, and beta-catenin were significantly increased in mice receiving low-dose methylphenidate for 28 days compared to controls. Interestingly, high-dose methylphenidate significantly decreased beta-catenin after 28 days and decreased VEGF, beta-catenin, and TrkB after 56 days compared to controls. Thus, low-dose methylphenidate appears to increase cell proliferation and cell survival in the hippocampus, and these effects may be mediated by increase in VEGF, TrkB, and beta-catenin. While high dose methylphenidate may initially increase neuronal proliferation, newly generated neurons are unable to survive long-term, possibly due to decrease in VEGF, TrkB and beta-catenin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

Download references

Acknowledgements

The authors would like to thank Dr. Donald Hoover for use of his microscope. This work was supported by the East Tennessee State University Research Development Committee Interdisciplinary program and the National Institutes of Health Grant C06RR0306551.

Funding

This work was funded by the East Tennessee State University Research Development Committee Interdisciplinary program and the National Institutes of Health Grant (C06RR0306551).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brooks B. Pond.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All experiments and procedures with animals were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals, and protocols were approved by the University Committee on Animal Care (UCAC) at East Tennessee State University.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oakes, H.V., DeVee, C.E., Farmer, B. et al. Neurogenesis within the hippocampus after chronic methylphenidate exposure. J Neural Transm 126, 201–209 (2019). https://doi.org/10.1007/s00702-018-1949-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-018-1949-2

Keywords

Navigation